Hodgkin's disease, splenectomy and secondary leukemia

Haematologica. 1993 Jul-Aug;78(4):258-9.
No abstract available

Publication types

  • Letter

MeSH terms

  • Adolescent
  • Adult
  • Alkylating Agents / adverse effects*
  • Antineoplastic Combined Chemotherapy Protocols / adverse effects*
  • Antineoplastic Combined Chemotherapy Protocols / therapeutic use
  • Child
  • Combined Modality Therapy
  • Female
  • Follow-Up Studies
  • Hodgkin Disease / drug therapy
  • Hodgkin Disease / radiotherapy
  • Hodgkin Disease / surgery
  • Hodgkin Disease / therapy*
  • Humans
  • Incidence
  • Leukemia / epidemiology
  • Leukemia / etiology*
  • Male
  • Mechlorethamine / administration & dosage
  • Mechlorethamine / adverse effects
  • Neoplasms, Second Primary / epidemiology
  • Neoplasms, Second Primary / etiology*
  • Prednisone / administration & dosage
  • Prednisone / adverse effects
  • Procarbazine / administration & dosage
  • Procarbazine / adverse effects
  • Risk
  • Splenectomy / adverse effects*
  • Vincristine / administration & dosage
  • Vincristine / adverse effects

Substances

  • Alkylating Agents
  • Procarbazine
  • Mechlorethamine
  • Vincristine
  • Prednisone

Supplementary concepts

  • MOPP protocol